Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cristal Therapeutics, PX Biosolutions to Develop Nanotech Vax Platform | Contract Pharma

What are you searching for?

Sign in
Breaking News

Cristal Therapeutics, PX Biosolutions to Develop Nanotech Vax Platform

Aims to develop superior vaccine products using CriVac technology

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Cristal Therapeutics has entered a collaboration with PX Biosolutions to research and develop the application of Cristal’s nanotechnology platform CriVac, for the design of innovative vaccines.
 
The CriVac platform enables the tailor-made development of well-characterized polymeric nanoparticles of a specific size, allowing optimal antigen presentation to dendritic cells.
 
PX Biosolutions, based in Melbourne, Australia, has developed DCtag vaccine formulations against various types of cancer. These vaccine formulations have been tested successfully in animal models.
 
Joost Holthuis, chief executive officer of Cristal Therapeutics said, “We are very excited about this collaboration that fits our strategy to set up product developments with companies active in the vaccine area. We are convinced that we can create additional value for patients and vaccine companies by development of superior vaccine products based on our CriVac technology.”
 
Ann Meulemans, chief executive officer of PX Biosolutions, said, “Our team is very enthusiastic about the possibility to enhance the flexibility of its DCtag platform by using the CriVac technology.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics